Showing 2201-2210 of 5615 results for "".
Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy
https://reachmd.com/programs/cme/resectable-head-neck-cancer-a-team-based-approach-to-perioperative-immunotherapy/35705/Resectable Head & Neck Cancer: A Team-Based Approach to Perioperative Immunotherapy6 Emerging Companies Poised to Redefine Medical Aesthetics
https://reachmd.com/topics/energy-based-devices/6-emerging-companies-poised-to-redefine-medical-aesthetics/49011/Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
https://reachmd.com/programs/project-oncology/relapsed-refractory-dlbcl-treatments/39971/Elevating CKD-aP Care: New Frontier
https://reachmd.com/programs/cme/elevating-ckd-ap-care-new-frontier/36298/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
https://reachmd.com/programs/cme/From-Pathway-to-Patient-Clinical-Advances-in-PI3K-Directed-Therapy-for-HR-HER2-mBC/35975/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.What to Know When Hiring a Public Relations Firm
https://reachmd.com/ma-issues-index/september-october-2025/what-to-know-when-hiring-a-public-relations-firm/39269/As the medical landscape evolves, even the most credentialed dermatologists can find themselves overshadowed by trending influencers or competitors who are simply more media-savvy.Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
https://reachmd.com/programs/cme/clinical-evidence-on-monotherapy-with-menin-inhibitors-in-rr-aml/36180/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Advances in Care for ATTR-CM: Current and Emerging Strategies
https://reachmd.com/programs/heart-matters/advances-in-care-for-attr-cm-current-and-emerging-strategies/33061/Increased recognition of transthyretin cardiac amyloidosis has led to a variety of innovative therapies. Here’s what you need to know.The Future Is Biochemical
https://reachmd.com/topics/practice-development/the-future-is-biochemical/35417/This frontier is being shaped by a category I call “biochemical cues”: modalities like exosomes, peptides, growth factors, PDRN (polydeoxyribonucleotide), and other regenerative approaches, which tap into the body’s own healing and repair mechanisms to deliver profound results.Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
https://reachmd.com/programs/cme/employing-immunotherapy-and-adcs-in-advanced-endometrial-and-cervical-cancers-current-and-emerging-therapies/14460/Our experts are breaking down evolving treatments for advanced endometrial & cervical cancer. Hear the latest data on immunotherapy and ADCs now!